Skip to main content
Clinical Trials/JPRN-UMIN000044311
JPRN-UMIN000044311
Completed
N/A

Effects on the cardiac conduction system revealed by analysis of heart rate variability in the use of Remimazolam (Single-blind, a prospective test) - Effects of Remimazolam on the cardiac conduction system (Single-blind, prospective study)

Kindai University Faculty of Medicine0 sites70 target enrollmentJune 1, 2021

Overview

Phase
N/A
Intervention
Not specified
Conditions
All diseases that require surgery under general anesthesia
Sponsor
Kindai University Faculty of Medicine
Enrollment
70
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 1, 2021
End Date
June 30, 2026
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\) Patients under the age of 20 at the time of obtaining the consent form 2\) Patients with allergies, hypersensitivity or tolerance to the drugs used 3\) Patients who meet the contraindications listed in the package insert of the drug to be used 4\) Patients with AST (GOT) or ALT (GPT) of 100 IU / L or more in preoperative general clinical examination 5\) Patients with Child\-Pugh classification B or C 6\) Patients with serum creatinine of 2\.0 mg / dL or higher in general preoperative laboratory tests 7\) Patients who have been using benzodiazepines for a long time 8\) Patients with organic abnormalities in the brain who may not be able to properly measure EEG and BIS values 9\) Patients scheduled to undergo epidural anesthesia / spinal anesthesia 10\) Patients with cardiac pacemakers and ICDs 11\) Lactating patients (except with the positive consent of the patient) 12\) Other patients judged to be inappropriate by the principal investigator

Outcomes

Primary Outcomes

Not specified

Similar Trials